This report contains market size and forecasts of Conjugate Vaccines in global, including the following market information:
Global Conjugate Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Conjugate Vaccines Market Sales, 2016-2021, 2022-2027, (K Doses)
Global top five Conjugate Vaccines companies in 2020 (%)
The global Conjugate Vaccines market was valued at 11890 million in 2020 and is projected to reach US$ 14570 million by 2027, at a CAGR of 5.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Conjugate Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Conjugate Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, By Type, 2020 (%)
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Global Conjugate Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, By Application, 2020 (%)
Children
Adults
Global Conjugate Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Conjugate Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Conjugate Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Conjugate Vaccines revenues share in global market, 2020 (%)
Key companies Conjugate Vaccines sales in global market, 2016-2021 (Estimated), (K Doses)
Key companies Conjugate Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Conjugate Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Conjugate Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Conjugate Vaccines Overall Market Size
2.1 Global Conjugate Vaccines Market Size: 2021 VS 2027
2.2 Global Conjugate Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Conjugate Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Conjugate Vaccines Players in Global Market
3.2 Top Global Conjugate Vaccines Companies Ranked by Revenue
3.3 Global Conjugate Vaccines Revenue by Companies
3.4 Global Conjugate Vaccines Sales by Companies
3.5 Global Conjugate Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Conjugate Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Conjugate Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjugate Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Conjugate Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Conjugate Vaccines Market Size Markets, 2021 & 2027
4.1.2 Monovalent Conjugate Vaccines
4.1.3 Multivalent Conjugate Vaccines
4.2 By Type - Global Conjugate Vaccines Revenue & Forecasts
4.2.1 By Type - Global Conjugate Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Conjugate Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Conjugate Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Conjugate Vaccines Sales & Forecasts
4.3.1 By Type - Global Conjugate Vaccines Sales, 2016-2021
4.3.2 By Type - Global Conjugate Vaccines Sales, 2022-2027
4.3.3 By Type - Global Conjugate Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Conjugate Vaccines Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Conjugate Vaccines Revenue & Forecasts
5.2.1 By Application - Global Conjugate Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Conjugate Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Conjugate Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Conjugate Vaccines Sales & Forecasts
5.3.1 By Application - Global Conjugate Vaccines Sales, 2016-2021
5.3.2 By Application - Global Conjugate Vaccines Sales, 2022-2027
5.3.3 By Application - Global Conjugate Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Conjugate Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Conjugate Vaccines Revenue & Forecasts
6.2.1 By Region - Global Conjugate Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Conjugate Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Conjugate Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Conjugate Vaccines Sales & Forecasts
6.3.1 By Region - Global Conjugate Vaccines Sales, 2016-2021
6.3.2 By Region - Global Conjugate Vaccines Sales, 2022-2027
6.3.3 By Region - Global Conjugate Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Conjugate Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Conjugate Vaccines Sales, 2016-2027
6.4.3 US Conjugate Vaccines Market Size, 2016-2027
6.4.4 Canada Conjugate Vaccines Market Size, 2016-2027
6.4.5 Mexico Conjugate Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Conjugate Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Conjugate Vaccines Sales, 2016-2027
6.5.3 Germany Conjugate Vaccines Market Size, 2016-2027
6.5.4 France Conjugate Vaccines Market Size, 2016-2027
6.5.5 U.K. Conjugate Vaccines Market Size, 2016-2027
6.5.6 Italy Conjugate Vaccines Market Size, 2016-2027
6.5.7 Russia Conjugate Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Conjugate Vaccines Market Size, 2016-2027
6.5.9 Benelux Conjugate Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Conjugate Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Conjugate Vaccines Sales, 2016-2027
6.6.3 China Conjugate Vaccines Market Size, 2016-2027
6.6.4 Japan Conjugate Vaccines Market Size, 2016-2027
6.6.5 South Korea Conjugate Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Conjugate Vaccines Market Size, 2016-2027
6.6.7 India Conjugate Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Conjugate Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Conjugate Vaccines Sales, 2016-2027
6.7.3 Brazil Conjugate Vaccines Market Size, 2016-2027
6.7.4 Argentina Conjugate Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Conjugate Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Conjugate Vaccines Sales, 2016-2027
6.8.3 Turkey Conjugate Vaccines Market Size, 2016-2027
6.8.4 Israel Conjugate Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Conjugate Vaccines Market Size, 2016-2027
6.8.6 UAE Conjugate Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Conjugate Vaccines Major Product Offerings
7.1.4 Novartis Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 Neuron Biotech
7.2.1 Neuron Biotech Corporate Summary
7.2.2 Neuron Biotech Business Overview
7.2.3 Neuron Biotech Conjugate Vaccines Major Product Offerings
7.2.4 Neuron Biotech Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 Neuron Biotech Key News
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporate Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Conjugate Vaccines Major Product Offerings
7.3.4 Serum Institute of India Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 Serum Institute of India Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Conjugate Vaccines Major Product Offerings
7.4.4 Pfizer Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Corporate Summary
7.5.2 Sanofi Pasteur Business Overview
7.5.3 Sanofi Pasteur Conjugate Vaccines Major Product Offerings
7.5.4 Sanofi Pasteur Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 Sanofi Pasteur Key News
7.6 Bharat Biotech
7.6.1 Bharat Biotech Corporate Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Conjugate Vaccines Major Product Offerings
7.6.4 Bharat Biotech Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 Bharat Biotech Key News
7.7 Biological
7.7.1 Biological Corporate Summary
7.7.2 Biological Business Overview
7.7.3 Biological Conjugate Vaccines Major Product Offerings
7.4.4 Biological Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 Biological Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Conjugate Vaccines Major Product Offerings
7.8.4 GlaxoSmithKline Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 GlaxoSmithKline Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Conjugate Vaccines Major Product Offerings
7.9.4 Merck Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 Merck Key News
7.10 CSL
7.10.1 CSL Corporate Summary
7.10.2 CSL Business Overview
7.10.3 CSL Conjugate Vaccines Major Product Offerings
7.10.4 CSL Conjugate Vaccines Sales and Revenue in Global (2016-2021)
7.10.5 CSL Key News
8 Global Conjugate Vaccines Production Capacity, Analysis
8.1 Global Conjugate Vaccines Production Capacity, 2016-2027
8.2 Conjugate Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Conjugate Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Conjugate Vaccines Supply Chain Analysis
10.1 Conjugate Vaccines Industry Value Chain
10.2 Conjugate Vaccines Upstream Market
10.3 Conjugate Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Conjugate Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Conjugate Vaccines in Global Market
Table 2. Top Conjugate Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Conjugate Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Conjugate Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Conjugate Vaccines Sales by Companies, (K Doses), 2016-2021
Table 6. Global Conjugate Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Conjugate Vaccines Price (2016-2021) & (USD/Doses)
Table 8. Global Manufacturers Conjugate Vaccines Product Type
Table 9. List of Global Tier 1 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL